Notably, PARK7+Mac−C2 and VIM+Mac−C1 exhibited a preference for expressing genes that were upregulated in M1 macrophages, suggesting their enhanced M1-like anti-tumor functions (Figure 3I). The gene discussed is MACC1; the disease is neoplasm.